Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 131-140 of 856

NICE consults on treatment for rare autoimmune disease and asks for further information from the manufacturer
NICE has today (23 July) published draft guidance on rituximab (MabThera, Roche Products).
July 23, 2013

NICE Citizens Council publishes final report on development of social care guidance
The Citizens Council, which advises the National Institute for Health and Care Excellence, has published its final report on factors that it believes should be considered when NICE develops social care guidance.
July 19, 2013

NICE draft guidance recommends drugs to treat chronic hepatitis C in children and young people
In draft guidance for consultation NICE recommends the use of peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people.
July 18, 2013

NICE guidance supports use of a device to visualise the airway in emergencies and improve patient safety
NICE today (17 July) publishes guidance supporting the NHS using a device to help health professionals keep patients? airways open when unexpected problems occur during procedures.
July 17, 2013

NICE guidance supports new device for assessing a pregnancy complication which affects thousands of women
NICE guidance published today (17 July) supports the use of a device to assess the potentially serious complication of unexplained vaginal wetness in pregnancy. The wetness could simply be leaking urine which is not a cause for immediate concern, or it could be leaking amniotic fluid, which would indicate that the fetal membranes had ruptured, with the potential for infection to occur.
July 17, 2013

NICE consults on newly updated draft recommendations for diagnosing and treating prostate cancer
The National Institute for Health and Care Excellence (NICE) is currently updating its clinical guideline on the diagnosis and treatment prostate cancer. As part of this process, draft recommendations have been published on the NICE website today for public consultation.
July 16, 2013

NICE consults on a new treatment for chronic myeloid leukaemia
NICE, the healthcare guidance body, has issued new preliminary draft guidance that does not recommend bosutinib (Bosulif, Pfizer) for previously treated chronic myeloid leukaemia.
July 16, 2013

NICE sets clear standards to ensure mothers and babies get the best care in the crucial weeks after birth
The National Institute for Health and Care Excellence (NICE) has issued standards to improve the quality of care and support for women and their babies in the postnatal period.
July 16, 2013

NICE consults on a new treatment for myelodysplastic syndromes
NICE, the healthcare guidance body, has issued new draft guidance that does not recommend lenalidomide (Revlimid, Celgene), for treating myelodysplastic syndromes.
July 11, 2013

NICE publishes guideline for treating people with acute heart attack
A new NICE guideline aims to improve the outcomes for people who have suffered the most severe type of heart attack.
July 10, 2013

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.